| |
|
|
|
|
|
|
|||
|
R Landolfi, R De Cristofaro, M Castagnola, E De Candia, G D'Onofrio, G Leone and B Bizzi
Department of Hematology, Catholic University, Rome, Italy.
Patients with myeloproliferative disorders (MPD) are known to have some
abnormalities of platelet glycoproteins (Gp). Quantitative changes of the
Gp Ib, IIb-IIIa, and/or their glucidic content have been reported. Since
the Gp IIb-IIIa complex plays a major role in fibrinogen binding by
activated platelets, we measured the platelet fibrinogen affinity in nine
patients with polycythemia vera (PV) and one subject with chronic myeloid
leukemia (CML) by the aggregometric method of Marguerie. In all patients
the Kd of the platelet fibrinogen reaction was significantly decreased as
compared to controls, with evidence in two cases with PV of a heterogeneity
of platelet-fibrinogen receptor sites. The measurement of 125I-labeled
fibrinogen-platelet binding, performed in seven patients (five PV and two
CML), showed receptor populations with increased (Kd1 = 0.58 + 0.3 X 10(7)
mol/L) and normal affinity (Kd2 = 5.12 + 3.1 X 10(7) mol/L). These results
demonstrate a heterogeneity of platelet-fibrinogen receptors in these
patients and may explain the thrombotic diathesis of MPD subjects.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1988 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||